Roivant Sciences Ltd. SEC filings ROIV
Roivant Sciences Ltd. has 995 filings in SEC EDGAR's recent list, going back to Mar 16, 2015. Its latest annual report, Form ARS, was filed on Jul 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jul 29, 2026 | — |
| DEF 14A | Proxy statement | Jul 29, 2026 | Sep 16, 2026 |
| DEF 14A | Proxy statement | Jul 29, 2025 | Sep 10, 2025 |
| DEFA14A | Additional proxy material | Jul 29, 2025 | — |
| DEFA14A | Additional proxy material | Jul 26, 2024 | — |
| DEF 14A | Proxy statement | Jul 26, 2024 | Sep 10, 2024 |
| DEFA14A | Additional proxy material | Jul 31, 2023 | — |
| DEF 14A | Proxy statement | Jul 31, 2023 | Sep 12, 2023 |
| DEFA14A | Additional proxy material | Jul 26, 2022 | — |
| DEF 14A | Proxy statement | Jul 26, 2022 | Sep 15, 2022 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ROIV (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Bermuda
- Headquarters
- London
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1635088
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.